ProfileGDS5822 / ILMN_2652226
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 51% 5% 25% 12% 20% 50% 47% 4% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 122.551
GSM1276600PDAC Late Ablation Control 29.65
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 112.425
GSM1276603PDAC Late Ablation 29.312
GSM1276604PDAC Late Ablation 312.220
GSM1303940PDAC Late Ablation_anti-CTLA4 122.450
GSM1303941PDAC Late Ablation_anti-CTLA4 223.347
GSM1303942PDAC Late Ablation_anti-CTLA4 33.64